EMFLAZA 6 mg/1
deflazacort · TABLET · PTC Therapeutics, Inc.
No Recall History
Plain English
Emflaza is an oral corticosteroid tablet used to treat Duchenne muscular dystrophy in patients. This prescription medication works by reducing inflammation and slowing muscle weakness associated with this genetic disorder.
Key Facts
- Brand Name
- EMFLAZA
- Generic Name
- deflazacort
- NDC Code (Product)
52856-501- Manufacturer
- PTC Therapeutics, Inc.
- Strength
- 6 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA208684
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 09/10/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is EMFLAZA used for?
Emflaza is an oral corticosteroid tablet used to treat Duchenne muscular dystrophy in patients. This prescription medication works by reducing inflammation and slowing muscle weakness associated with this genetic disorder.
Is EMFLAZA a controlled substance?
EMFLAZA is not classified as a controlled substance by the DEA.
What is the generic name for EMFLAZA?
The generic name for EMFLAZA is deflazacort. There are 10 other brand versions of deflazacort.
What is the NDC code for EMFLAZA 6 mg/1?
The NDC (National Drug Code) for EMFLAZA 6 mg/1 is 52856-501, listed by PTC Therapeutics, Inc..